|
|
Volumn 16, Issue SUPPL. 2, 2009, Pages 2-5
|
|
Routine use of Xeomin® in patients previously treated with Botox®: Long term results
|
|
Author keywords
Botulinum toxin type A; Complexing proteins; Conversion ratio; Dystonia; Efficacy; Hemifacial spasm; Hyperhidrosis; Hypersalivation; Re innervation synkinesias; Safety; Spasticity
|
|
Indexed keywords
BOTULINUM TOXIN A;
ANTIPARKINSON AGENT;
BOTULINUM TOXIN;
ADULT;
AGED;
ARTICLE;
BIOEQUIVALENCE;
BLEPHAROSPASM;
CERVICAL DYSTONIA;
CONTROLLED STUDY;
DRUG INDICATION;
DRUG SUBSTITUTION;
DRY EYE;
DYSPHAGIA;
DYSPNEA;
DYSTONIA;
FEMALE;
HEMIFACIAL SPASM;
HUMAN;
HYPERHIDROSIS;
HYPERSALIVATION;
INTESTINE MOTILITY;
MAJOR CLINICAL STUDY;
MALAISE;
MALE;
MICTURITION DISORDER;
MUSCLE WEAKNESS;
NEUROMUSCULAR BLOCKING;
OUTCOME ASSESSMENT;
PHOTOSENSITIVITY;
PRIORITY JOURNAL;
RETREATMENT;
SIDE EFFECT;
SPASTICITY;
SWEATING;
SYNKINESIS;
VISUAL IMPAIRMENT;
XEROSTOMIA;
CLINICAL TRIAL;
CROSSOVER PROCEDURE;
INTERVIEW;
MIDDLE AGED;
OFF LABEL DRUG USE;
TIME;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTI-DYSKINESIA AGENTS;
BOTULINUM TOXIN TYPE A;
BOTULINUM TOXINS;
CROSS-OVER STUDIES;
DYSTONIA;
FEMALE;
HEMIFACIAL SPASM;
HUMANS;
HYPERHIDROSIS;
INTERVIEWS AS TOPIC;
MALE;
MIDDLE AGED;
MUSCLE SPASTICITY;
OFF-LABEL USE;
SIALORRHEA;
SYNKINESIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 72849120235
PISSN: 13515101
EISSN: 14681331
Source Type: Journal
DOI: 10.1111/j.1468-1331.2009.02877.x Document Type: Article |
|
Times cited : (78)
|
|
References (5)
|
